Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
- PMID: 17210912
- PMCID: PMC1783424 (V体育ios版)
- DOI: 10.1073/pnas.0610117104
"V体育平台登录" Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
V体育安卓版 - Abstract
Like many epithelial tumors, head and neck squamous cell carcinoma (HNSCC) contains a heterogeneous population of cancer cells. We developed an immunodeficient mouse model to test the tumorigenic potential of different populations of cancer cells derived from primary, unmanipulated human HNSCC samples. We show that a minority population of CD44(+) cancer cells, which typically comprise <10% of the cells in a HNSCC tumor, but not the CD44(-) cancer cells, gave rise to new tumors in vivo. Immunohistochemistry revealed that the CD44(+) cancer cells have a primitive cellular morphology and costain with the basal cell marker Cytokeratin 5/14, whereas the CD44(-) cancer cells resemble differentiated squamous epithelium and express the differentiation marker Involucrin VSports手机版. The tumors that arose from purified CD44(+) cells reproduced the original tumor heterogeneity and could be serially passaged, thus demonstrating the two defining properties of stem cells: ability to self-renew and to differentiate. Furthermore, the tumorigenic CD44(+) cells differentially express the BMI1 gene, at both the RNA and protein levels. By immunohistochemical analysis, the CD44(+) cells in the tumor express high levels of nuclear BMI1, and are arrayed in characteristic tumor microdomains. BMI1 has been demonstrated to play a role in self-renewal in other stem cell types and to be involved in tumorigenesis. Taken together, these data demonstrate that cells within the CD44(+) population of human HNSCC possess the unique properties of cancer stem cells in functional assays for cancer stem cell self-renewal and differentiation and form unique histological microdomains that may aid in cancer diagnosis. .
Conflict of interest statement
Conflict of interest statement: I V体育安卓版. L. W. was a member of the scientific advisory board of Amgen and owns significant Amgen stock; and I. L. W. cofounded and consulted for Systemix, is a cofounder and director of Stem Cells, Inc. , and recently cofounded Cellerant, Inc.
Figures





References
-
- Jain S, Khuri FR, Shin DM. Curr Probl Cancer. 2004;28:265–286. - PubMed
-
- Aubele M, Werner M. Anal Cell Pathol. 1999;19:53–58. - "V体育安卓版" PMC - PubMed
-
- Golub TR. N Engl J Med. 2001;344:601–602. - PubMed
-
- Pardal R, Clarke MF, Morrison SJ. Nat Rev Cancer. 2003;3:895–902. - PubMed
-
- Reya T, Morrison SJ, Clarke MF, Weissman IL. Nature. 2001;414:105–111. - PubMed (V体育ios版)
Publication types
"VSports手机版" MeSH terms
- "VSports最新版本" Actions
- VSports注册入口 - Actions
- V体育官网入口 - Actions
- Actions (VSports)
- VSports注册入口 - Actions
- VSports在线直播 - Actions
- Actions (V体育平台登录)
- Actions (VSports手机版)
Substances
Grants and funding (VSports)
"V体育安卓版" LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
V体育安卓版 - Miscellaneous